Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100,000
Closed -$478K 6310
2025
Q2
$478K Buy
+100,000
New +$574K ﹤0.01% 4946
2021
Q1
Sell
-6,000
Closed -$238K 6324
2020
Q4
$238K Hold
6,000
﹤0.01% 4707
2020
Q3
$235 Buy
+6,000
New +$230K ﹤0.01% 3990
2020
Q1
Sell
-10,000
Closed -$326K 4274
2019
Q4
$326K Sell
10,000
-10,000
-50% -$329K ﹤0.01% 3619
2019
Q3
$681K Buy
+20,000
New +$692K ﹤0.01% 3070

Other funds holding NEOG

Israel Englander's NEOG Position: Q2 2026 in Review

Israel Englander sold out of Neogen (NEOG) in Q2 2026, closing a stake of 30,555 shares — an estimated $284K sold.

Israel Englander first reported a position in NEOG in Q3 2014 and held it in 30 quarters. The position peaked at $38.3M in Q3 2022. 314 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Israel Englander reported no remaining Neogen position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 30,555 Neogen shares in Q2 2026, an estimated $284K.
  • Israel Englander first reported a position in Neogen in Q3 2014 and held it in 30 quarters.
  • Israel Englander's Neogen position peaked at $38.3M in Q3 2022.
  • 314 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.